The metagenomics market size has grown rapidly in recent years. It will grow from $2.01 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to microbiome research advancements, disease association studies, environmental monitoring needs, agricultural and food applications, biotechnology and industrial processes.
The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $4 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition.
The growing incidence of infectious diseases is a major factor contributing to the expansion of the metagenomics market. Infectious diseases, often referred to as transmissible diseases, are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, which can be spread from person to person or through various transmission methods. Metagenomics plays a vital role in studying infectious diseases by analyzing the genetic material of microbial communities. This approach allows for a thorough examination of microbial communities linked to infectious agents, offering insights into their composition, genetic diversity, and potential interactions. For example, a report released by the UK Health Security Agency in February 2024 indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases recorded compared to 4,380 in 2022. Consequently, the rising prevalence of infectious diseases is propelling the growth of the metagenomics market.
The expanding agriculture sector is expected to drive the growth of the metagenomics market in the future. The agriculture sector, commonly known as the agricultural industry or farming sector, includes a wide range of activities related to crop cultivation, livestock rearing, and the production of food, fiber, and other agricultural products. Metagenomics enhances precision agriculture by providing insights into microbial communities, enabling farmers to make informed decisions regarding resource management, irrigation, and pest control. For example, a report from the Plant Based Foods Association in January 2023 indicated that plant-based food sales grew by 6.6% in 2022, an increase from 5.9% in 2021, alongside a 10% rise in average retail prices. Thus, the growth of the agriculture sector is fueling the expansion of the metagenomics market.
A prominent trend in the metagenomics market is the adoption of technological advancements. Major companies in the market are actively embracing new genomics technologies to enhance their observational capabilities and maintain their market position. For instance, CD Genomics, a genomics services company based in the US, introduced the Long-Read Metagenomic Sequencing service in May 2023. This cutting-edge technology empowers researchers and scientists to gain a deeper and more accurate understanding of microbial communities. With features such as enhanced resolution, species identification, functional annotation, and comparative analysis, this advanced method is expected to revolutionize metagenomics research by providing unprecedented insights into microbial communities.
Leading companies in the metagenomics market are also focusing on developing innovative products, such as production-scale sequencers, to cater to larger customer bases, increase sales, and boost revenue. A production-scale sequencer is designed for high-throughput DNA sequencing tasks on a large scale. In September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus). These sequencers enable quicker, more potent, and environmentally sustainable sequencing. The NovaSeq X Plus, in particular, has the capacity to generate over 20,000 whole genomes annually, showcasing a throughput 2.5 times greater than its predecessors. The efficiency increase accelerates genomic discovery, enhances clinical insights, and contributes to a deeper understanding of diseases. Additionally, the NovaSeq X exhibits a strong commitment to environmental sustainability by significantly reducing packaging waste and weight, along with a 50% reduction in plastic usage compared to its predecessor, the NovaSeq 6000.
In June 2022, Illumina Inc. acquired IDbyDNA, a US-based biotechnology company specializing in metagenomic technology for infectious disease testing and pathogen surveillance, for an undisclosed amount. This acquisition is aimed at accelerating Illumina Inc.'s growth in the metagenomics market and expanding its range of solutions for customers.
Major companies operating in the metagenomics market include Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation.
North America was the largest region in the global metagenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Metagenomics is a scientific research field that explores genetic material (DNA or RNA) directly extracted from environmental samples or complex microbial communities. Rather than isolating and studying individual organisms, metagenomics focuses on analyzing the collective genomic information present in a given sample.
The primary types of products associated with metagenomics include instruments, kits and reagents, and software and services. Instruments are tools and equipment used for sample collection, DNA and RNA extraction, and various workflows such as sequencing, pre-sequencing, and data analysis. Metagenomic applications span diverse fields, including environmental studies, clinical diagnostics, drug discovery, biotechnology, food and nutrition. These products are utilized by a range of end-users, including pharmaceutical industries, research laboratories, biotechnology companies, pathology laboratories, as well as academic and research institutes.
The metagenomics market research report is one of a series of new reports that provides metagenomics market statistics, including metagenomics industry global market size, regional shares, competitors with a metagenomics market share, detailed metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. This metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The metagenomics market consists of revenues earned by entities by providing metagenomic services such as metatranscriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and metatranscriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $4 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition.
The growing incidence of infectious diseases is a major factor contributing to the expansion of the metagenomics market. Infectious diseases, often referred to as transmissible diseases, are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, which can be spread from person to person or through various transmission methods. Metagenomics plays a vital role in studying infectious diseases by analyzing the genetic material of microbial communities. This approach allows for a thorough examination of microbial communities linked to infectious agents, offering insights into their composition, genetic diversity, and potential interactions. For example, a report released by the UK Health Security Agency in February 2024 indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases recorded compared to 4,380 in 2022. Consequently, the rising prevalence of infectious diseases is propelling the growth of the metagenomics market.
The expanding agriculture sector is expected to drive the growth of the metagenomics market in the future. The agriculture sector, commonly known as the agricultural industry or farming sector, includes a wide range of activities related to crop cultivation, livestock rearing, and the production of food, fiber, and other agricultural products. Metagenomics enhances precision agriculture by providing insights into microbial communities, enabling farmers to make informed decisions regarding resource management, irrigation, and pest control. For example, a report from the Plant Based Foods Association in January 2023 indicated that plant-based food sales grew by 6.6% in 2022, an increase from 5.9% in 2021, alongside a 10% rise in average retail prices. Thus, the growth of the agriculture sector is fueling the expansion of the metagenomics market.
A prominent trend in the metagenomics market is the adoption of technological advancements. Major companies in the market are actively embracing new genomics technologies to enhance their observational capabilities and maintain their market position. For instance, CD Genomics, a genomics services company based in the US, introduced the Long-Read Metagenomic Sequencing service in May 2023. This cutting-edge technology empowers researchers and scientists to gain a deeper and more accurate understanding of microbial communities. With features such as enhanced resolution, species identification, functional annotation, and comparative analysis, this advanced method is expected to revolutionize metagenomics research by providing unprecedented insights into microbial communities.
Leading companies in the metagenomics market are also focusing on developing innovative products, such as production-scale sequencers, to cater to larger customer bases, increase sales, and boost revenue. A production-scale sequencer is designed for high-throughput DNA sequencing tasks on a large scale. In September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus). These sequencers enable quicker, more potent, and environmentally sustainable sequencing. The NovaSeq X Plus, in particular, has the capacity to generate over 20,000 whole genomes annually, showcasing a throughput 2.5 times greater than its predecessors. The efficiency increase accelerates genomic discovery, enhances clinical insights, and contributes to a deeper understanding of diseases. Additionally, the NovaSeq X exhibits a strong commitment to environmental sustainability by significantly reducing packaging waste and weight, along with a 50% reduction in plastic usage compared to its predecessor, the NovaSeq 6000.
In June 2022, Illumina Inc. acquired IDbyDNA, a US-based biotechnology company specializing in metagenomic technology for infectious disease testing and pathogen surveillance, for an undisclosed amount. This acquisition is aimed at accelerating Illumina Inc.'s growth in the metagenomics market and expanding its range of solutions for customers.
Major companies operating in the metagenomics market include Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation.
North America was the largest region in the global metagenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Metagenomics is a scientific research field that explores genetic material (DNA or RNA) directly extracted from environmental samples or complex microbial communities. Rather than isolating and studying individual organisms, metagenomics focuses on analyzing the collective genomic information present in a given sample.
The primary types of products associated with metagenomics include instruments, kits and reagents, and software and services. Instruments are tools and equipment used for sample collection, DNA and RNA extraction, and various workflows such as sequencing, pre-sequencing, and data analysis. Metagenomic applications span diverse fields, including environmental studies, clinical diagnostics, drug discovery, biotechnology, food and nutrition. These products are utilized by a range of end-users, including pharmaceutical industries, research laboratories, biotechnology companies, pathology laboratories, as well as academic and research institutes.
The metagenomics market research report is one of a series of new reports that provides metagenomics market statistics, including metagenomics industry global market size, regional shares, competitors with a metagenomics market share, detailed metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. This metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The metagenomics market consists of revenues earned by entities by providing metagenomic services such as metatranscriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and metatranscriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Metagenomics Market Characteristics3. Metagenomics Market Trends and Strategies4. Metagenomics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Metagenomics Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Metagenomics Market34. Recent Developments in the Metagenomics Market
5. Global Metagenomics Growth Analysis and Strategic Analysis Framework
6. Metagenomics Market Segmentation
7. Metagenomics Market Regional and Country Analysis
8. Asia-Pacific Metagenomics Market
9. China Metagenomics Market
10. India Metagenomics Market
11. Japan Metagenomics Market
12. Australia Metagenomics Market
13. Indonesia Metagenomics Market
14. South Korea Metagenomics Market
15. Western Europe Metagenomics Market
16. UK Metagenomics Market
17. Germany Metagenomics Market
18. France Metagenomics Market
19. Italy Metagenomics Market
20. Spain Metagenomics Market
21. Eastern Europe Metagenomics Market
22. Russia Metagenomics Market
23. North America Metagenomics Market
24. USA Metagenomics Market
25. Canada Metagenomics Market
26. South America Metagenomics Market
27. Brazil Metagenomics Market
28. Middle East Metagenomics Market
29. Africa Metagenomics Market
30. Metagenomics Market Competitive Landscape and Company Profiles
31. Metagenomics Market Other Major and Innovative Companies
35. Metagenomics Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Metagenomics Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on metagenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for metagenomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metagenomics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Instruments; Kits and Reagents; Software and Services2) By Workflow: Sequencing; Pre-Sequencing; Data Analysis
3) By Application: Environmental; Clinical Diagnostics; Drug Discovery; Biotechnology; Food and Nutrition; Other Applications
4) By End User: Pharmaceutical Industries; Research Laboratories; Biotechnology Companies; Pathology Laboratories; Academic and Research Institutes
Subsegments:
1) By Instruments: DNA Sequencers; PCR Machines; Microarray Systems; Mass Spectrometers2) By Kits and Reagents: DNA Extraction Kits; Library Preparation Kits; Amplification Kits; Sequencing Reagents
3) By Software and Services: Data Analysis Software; Bioinformatics Services; Cloud-Based Data Storage; Consultation Services
Key Companies Mentioned: Illumina Inc.; Promega Corporation; Qiagen N.V.; Thermo Fisher Scientific Inc.; Perkin Elmer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Illumina Inc.
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
- Perkin Elmer Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Novogene Co. Ltd.
- Oxford Nanopore Technologies Limited
- BGI Group
- Eurofins Scientific SE
- Arc Bio LLC
- Computomics GmbH
- Enterome Bioscience
- TAKARA BIO INC.
- Danaher Corporation
- ELITechGroup
- Metagenomi
- Cosmosid Inc.
- Pattern Ag
- Tiny Health
- MATIS OHF
- Adapsyn Bioscience
- Precidiag Inc.
- One Codex Inc.
- MetaBi Inc.
- Zymo Research Corporation
- Bluebee Holding BV
- Maverix Biomics Inc.
- Lucigen Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | February 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 2.32 Billion |
Forecasted Market Value ( USD | $ 4 Billion |
Compound Annual Growth Rate | 14.7% |
Regions Covered | Global |
No. of Companies Mentioned | 30 |